Physician profile
Mark D Medici
NPI 1750437828
$2,447.11
in general payments reported to CMS, 2019-2025
12 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $799 · 2020: $293 · 2021: $378 · 2022: $175 · 2023: $432 · 2024: $175 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $946.82 | 2019-2025 | Mako, Gamma |
| Smith+Nephew, INC. | $910.83 | 2019-2024 | Lens 4k, Goflo Pump, Rf20000 |
| Heron Therapeutics, INC. | $124.86 | 2021 | |
| Sanofi-Aventis U.S. LLC | $101.73 | 2019 | |
| Integra Lifesciences Corporation | $90.33 | 2019-2020 | |
| Seapearl East, INC | $89.80 | 2019-2023 | |
| Fidia Pharma USA INC. | $49.53 | 2019-2020 | |
| Depuy Synthes Sales INC. | $42.58 | 2019-2020 | |
| Kci USA, INC. | $27.60 | 2019 | |
| Ferring Pharmaceuticals INC. | $26.87 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.83 | 2019 | |
| Dynasplint Systems INC. | $16.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Medici listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.